Show simple item record

dc.contributor.authorAL Qtaish, Nuseibah
dc.contributor.authorVillate Beitia, Ane Ilia
dc.contributor.authorGallego Garrido, Idoia
dc.contributor.authorMartínez Navarrete, Gema
dc.contributor.authorSoto-Sánchez, Cristina
dc.contributor.authorSainz Ramos, Myriam
dc.contributor.authorLópez Méndez, Tania Belén
dc.contributor.authorParedes, Alejandro Javier
dc.contributor.authorChichón, Francisco Javier
dc.contributor.authorZamarreño, Noelia
dc.contributor.authorFernández, Eduardo
dc.contributor.authorPuras Ochoa, Gustavo
dc.contributor.authorPedraz Muñoz, José Luis ORCID
dc.date.accessioned2023-06-23T16:38:54Z
dc.date.available2023-06-23T16:38:54Z
dc.date.issued2023-05
dc.identifier.citationInternational Journal of Pharmaceutics 639 : (2023) // Article ID 122968es_ES
dc.identifier.issn0378-5173
dc.identifier.issn1873-3476
dc.identifier.urihttp://hdl.handle.net/10810/61613
dc.description.abstractNanodiamonds were combined with niosome, and resulting formulations were named as nanodiasomes, which were evaluated in terms of physicochemical features, cellular internalization, cell viability and transfection efficiency both in in vitro and in in vivo conditions. Such parameters were analyzed at 4 and 25 °C, and at 15 and 30 days after their elaboration. Nanodiasomes showed a particle size of 128 nm that was maintained over time inside the ± 10% of deviation, unless after 30 days of storage at 25 °C. Something similar occurred with the initial zeta potential value, 35.2 mV, being both formulations more stable at 4 °C. The incorporation of nanodiamonds into niosomes resulted in a 4-fold increase of transfection efficiency that was maintained over time at 4 and 25 °C. In vivo studies reported high transgene expression of nanodiasomes after subretinal and intravitreal administration in mice, when injected freshly prepared and after 30 days of storage at 4 °C.es_ES
dc.description.sponsorshipThis work was supported by the Basque Country Government (Consolidated Groups, IT1448-22 and by CIBER -Consorcio Centro de Investigación Biomédica en Red- CB06/01/1028, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. Authors wish to thank: ICTS “NANBIOSIS”, specifically the Drug Formulation Unit (U10) of the CIBER in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) for the intellectual and technical assistance. Authors also thank SGIker (UPV/EHU) for technical and human support. Authors acknowledge Rocio Arranz, access to the cryoEM CSIC facility in the context of the CRIOMECORR project (ESFRI-2019-01-CSIC-16). I.V.B. thanks the University of the Basque Country (UPV/EHU) for the granted postdoctoral fellowship (call for the Specialization of Doctor Researcher Personnel of the UPV/EHU, grant reference: ESPDOC19/47). M.S.R. thanks the University of the Basque Country (UPV/EHU) for the granted pre-doctoral fellowship (PIF17/79).es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectnanodiamondes_ES
dc.subjectniosomees_ES
dc.subjectnon-virales_ES
dc.subjectgene deliveryes_ES
dc.subjectstabilityes_ES
dc.subjectretinaes_ES
dc.titleLong-term biophysical stability of nanodiamonds combined with lipid nanocarriers for non-viral gene delivery to the retinaes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0378517323003885es_ES
dc.identifier.doi10.1016/j.ijpharm.2023.122968
dc.departamentoesFisiologíaes_ES
dc.departamentoeuFisiologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Except where otherwise noted, this item's license is described as © 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)